Evaluation of the impact of once weekly dulaglutide on patient-reported outcomes in Japanese patients with type 2 diabetes: comparisons with liraglutide, insulin glargine, and placebo in two randomized studies
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1477-7525
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Evaluation of the impact of once weekly dulaglutide on patient-reported outcomes in Japanese patients with type 2 diabetes: comparisons with liraglutide, insulin glargine, and placebo in two randomized studies ; volume:15 ; number:1 ; day:12 ; month:6 ; year:2017 ; pages:1-10 ; date:12.2017
Health and quality of life outcomes ; 15, Heft 1 (12.6.2017), 1-10, 12.2017
- Schlagwort
-
Endokrinologie
- Urheber
-
Suzuki, Shuichi
- Beteiligte Personen und Organisationen
-
Oura, Tomonori
Takeuchi, Masakazu
Boye, Kristina S.
SpringerLink (Online service)
- DOI
-
10.1186/s12955-017-0696-7
- URN
-
urn:nbn:de:1111-20170906481
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:35 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Suzuki, Shuichi
- Oura, Tomonori
- Takeuchi, Masakazu
- Boye, Kristina S.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Once More with Feeling
Once more, with Feeling
Treatment of patients with type 2 diabetes with exenatide once weekly versus oral glucose-lowering medications or insulin glargine: achievement of glycemic and cardiovascular goals
Once-Weekly Semaglutide Versus Once-Daily Liraglutide for the Treatment of Type 2 Diabetes: A Long-Term Cost-Effectiveness Analysis in Estonia
Liraglutide restores impaired associative learning in individuals with obesity
Management of Patients with Type 2 Diabetes with Once-Weekly Semaglutide Versus Dulaglutide, Exenatide ER, Liraglutide and Lixisenatide: A Cost-Effectiveness Analysis in the Danish Setting
Evaluating the Long-Term Cost-Effectiveness of Once-Weekly Semaglutide Versus Once-Daily Liraglutide for the Treatment of Type 2 Diabetes in the UK
Ida & Laura; Once more with feeling
VIII. With the B.E.F. once more
Learn Once - Write Anywhere with React
Ida & Laura : Once More With Feeling
Inequality Comparisons with Ordinal Data
Once More with Feeling
Once more, with Feeling
Treatment of patients with type 2 diabetes with exenatide once weekly versus oral glucose-lowering medications or insulin glargine: achievement of glycemic and cardiovascular goals
Once-Weekly Semaglutide Versus Once-Daily Liraglutide for the Treatment of Type 2 Diabetes: A Long-Term Cost-Effectiveness Analysis in Estonia
Liraglutide restores impaired associative learning in individuals with obesity
Management of Patients with Type 2 Diabetes with Once-Weekly Semaglutide Versus Dulaglutide, Exenatide ER, Liraglutide and Lixisenatide: A Cost-Effectiveness Analysis in the Danish Setting
Evaluating the Long-Term Cost-Effectiveness of Once-Weekly Semaglutide Versus Once-Daily Liraglutide for the Treatment of Type 2 Diabetes in the UK
Ida & Laura; Once more with feeling
VIII. With the B.E.F. once more
Learn Once - Write Anywhere with React
Ida & Laura : Once More With Feeling
Inequality Comparisons with Ordinal Data
Once More with Feeling
Once more, with Feeling
Treatment of patients with type 2 diabetes with exenatide once weekly versus oral glucose-lowering medications or insulin glargine: achievement of glycemic and cardiovascular goals
Once-Weekly Semaglutide Versus Once-Daily Liraglutide for the Treatment of Type 2 Diabetes: A Long-Term Cost-Effectiveness Analysis in Estonia
Liraglutide restores impaired associative learning in individuals with obesity
Management of Patients with Type 2 Diabetes with Once-Weekly Semaglutide Versus Dulaglutide, Exenatide ER, Liraglutide and Lixisenatide: A Cost-Effectiveness Analysis in the Danish Setting
Evaluating the Long-Term Cost-Effectiveness of Once-Weekly Semaglutide Versus Once-Daily Liraglutide for the Treatment of Type 2 Diabetes in the UK
Ida & Laura; Once more with feeling
VIII. With the B.E.F. once more
Learn Once - Write Anywhere with React
Ida & Laura : Once More With Feeling